Proteome completes TB milestone
Tuesday, 17 June, 2008
Proteome Systems (ASX: PXL) has completed the preparations necessary to conduct a feasibility test of its collaborative agreement with Becton Dickinson (BD) to develop a new tuberculosis test.
PXL has defined a sample processing strategy for a proposed in-field diagnostics test. This achievement will trigger a further payment from BD once the feasibility stage has been completed.
If the feasibility tests are successful, BD will pay PXL both up-front and milestone payments for the right to co-develop and market the new test.
The tests promise to be much more accurate and rapid than the current method of testing for tuberculosis, sputum spear microscopy, which hasn't changed significantly in nearly 130 years.
Indigenous-led initiative to resurrect the South Island Giant Moa
New Zealand's Ngāi Tahu Research Centre has partnered with Colossal Biosciences and Sir Peter...
Abnormal brain protein targeted in Parkinson's study
Researchers have identified a new brain protein involved in the development of Parkinson's...
Epilepsy disease model treated in a laboratory dish
A research team has used an epilepsy-like disease model in a laboratory dish to demonstrate that...
